Regulations for Analytical development USFDA/ICH/USP perspectives

Prezentace | 2024 | Agilent TechnologiesInstrumentace
HPLC
Zaměření
Farmaceutická analýza
Výrobce
Agilent Technologies
PDF verze ke stažení a čtení
 

Podobná PDF

Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin
AGILENT SOLUTIONS FOR QUALITY-BY-DESIGN IMPLEMENTATION IN PHARMACEUTICAL DEVELOPMENT
Method Makeover: Updating older HPLC methods
Method Makeover: Updating older HPLC methods
2024|Agilent Technologies|Prezentace
Quality‑by‑Design Approach to Stability Indicating Method Development for Linagliptin Drug Product